Novartis | NOVN - Loan Capital

Stock Price
114.72
Daily Change
0.64 0.56%
Monthly
-4.26%
Yearly
21.77%
Q2 Forecast
111.47

Novartis reported $29.59B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alcon AG USD 4.59B 0 Dec/2025
Almirall EUR 324.81M 61.32M Dec/2025
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Autolus Therapeutics Ltd USD 251.94M 7.31M Sep/2025
Bayer EUR 31.83B 877M Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Fresenius Medical Care EUR 4.85B 4.49B Dec/2025
Galapagos EUR 5.19M 574K Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
Gilead Sciences USD 22.13B 6M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GRIFOLS EUR 8.47B 624.81M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.73B 277M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Novo Nordisk DKK 118.94B 29.76B Dec/2025
Orion EUR 110.6M 4.7M Mar/2026
Pfizer USD 57.41B 93M Sep/2025
Philips EUR 6.93B 303M Dec/2025
Recordati EUR 2.18B 89.51M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
UCB EUR 2.18B 634M Dec/2025